Hopefully sufficient to generate interest from the institutional "green" and alternative funds. Liquidity is still an issue for this stock.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025